Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for HIV-associated Neurocognitive Disorder
NCT02743598Phase 4Terminated
- Sponsor
- Temple University
- Start
- Sep 2016
- Primary completion
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in cognitive impairment, type 2 diabetes mellitus (T2DM), sponsored by Temple University. Started Sep 2016; status: terminated.
02
Drugs
03
Conditions
cognitive impairmenttype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02743598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743598.